ReviewCells2026

Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Chronic Liver Diseases: Translating Mechanistic Insights into Clinical Practice and Future Perspectives.

Mario Romeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.